Stock Research: Veru

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Veru

NasdaqCM:VERU US92536C1036
4
  • Value
    38
  • Growth
    11
  • Safety
    Safety
    23
  • Combined
    7
  • Sentiment
    16
  • 360° View
    360° View
    4
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Veru Inc. is a biopharmaceutical company focused on developing medicines for metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its main businesses involve drug development programs for enobosarm and sabizabulin. In the last fiscal year, the company had a market cap of $85 million, profits of $6 million, revenue of $17 million, and 210 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 4 (better than 4% compared with alternatives), overall professional sentiment and financial characteristics for the stock Veru are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Veru. The consolidated Value Rank has a low rank of 23 which means that the share price of Veru is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 77% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 11, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 11% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 38, which means that the company has a riskier financing structure than 62% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 16, which means that professional investors are more pessimistic about the stock than for 84% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
23 11 10 9
Growth
11 95 3 45
Safety
Safety
38 57 4 66
Sentiment
16 26 12 51
360° View
360° View
4 54 1 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
69 64 71 88
Opinions Change
31 83 50 50
Pro Holdings
n/a 33 1 65
Market Pulse
1 1 9 16
Sentiment
16 26 12 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
23 11 10 9
Growth
11 95 3 45
Safety Safety
38 57 4 66
Combined
7 75 1 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
22 22 22 22
Price vs. Earnings (P/E)
20 1 11 33
Price vs. Book (P/B)
46 47 35 62
Dividend Yield
1 1 1 1
Value
23 11 10 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
33 51 1 82
Profit Growth
45 53 55 1
Capital Growth
15 87 7 71
Stock Returns
9 71 5 23
Growth
11 95 3 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
58 64 44 76
Refinancing
55 78 21 71
Liquidity
10 4 13 17
Safety Safety
38 57 4 66

Similar Stocks

Discover high‑ranked alternatives to Veru and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.